M&ANeogap fully takes over TCER Oncology sharesLatest NewsSwedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders. Read more 19 June 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/EpiTcer.png 721 1280 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-06-19 22:10:562024-07-10 06:19:01Neogap fully takes over TCER Oncology shares